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Abstract: Growing evidence has demonstrated that the extracts of different holothurian species exert
beneficial effects on human health. Triple negative breast cancers (TNBC) are highly malignant
tumors that present a poor prognosis due to the lack of effective targeted therapies. In the attempt
to identify novel compounds that might counteract TNBC cell growth, we studied the effect of the
exposure of the TNBC cell line MDA-MB231 to total and filtered aqueous extracts of the coelomic fluid
obtained from the sea cucumber Holoturia tubulosa, a widespread species in the Mediterranean Sea.
In particular, we examined cell viability and proliferative behaviour, cell cycle distribution, apoptosis,
autophagy, and mitochondrial metabolic/cell redox state. The results obtained indicate that both total
and fractionated extracts are potent inhibitors of TNBC cell viability and growth, acting through
both an impairment of cell cycle progression and mitochondrial transmembrane potential and a
stimulation of cellular autophagy, as demonstrated by the increase of the acidic vesicular organelles
and of the intracellular protein markers beclin-1, and total LC3 and LC3-II upon early exposure to the
preparations. Identification of the water-soluble bioactive component(s) present in the extract merit
further investigation aiming to develop novel prevention and/or treatment agents efficacious against
highly metastatic breast carcinomas.
Keywords: Holothuria tubulosa; coelomic fluid; breast cancer; cell viability; cell cycle; mitochondrial
function; autophagy
1. Introduction
Holothurians, also named sea cucumbers, belong to the class Holothuroidea (phylum
Echinodermata), which includes around 1250 described living species worldwide. Holothurians
have been widely studied in the last two decades for their high nutritious value and beneficial effects
on human health [1–3], which have made them an object of investigation for possible therapeutic
uses. In fact, the efficacy of holothurians to alleviate a number of different pathologies (asthma,
rheumatism, hypertension, impotence, and others) is well known from Asian traditional medicine,
as reported in the literature [4,5]. Furthermore, growing evidence has demonstrated that the extracts
of different holothurian species are endowed with several varied biological and pharmacological
properties, spanning from anti-angiogenic and anticancer to antimicrobial and anticoagulant activities
(e.g., [1,6,7]). Such effects have been ascribed to the presence of numerous bioactive compounds
among which the most characterized to date are the triterpene glycosides saponins, accounting for
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more than 300 different molecules, along with components of various macromolecular nature, such as
glycosaminoglycans, phenolics, and peptides [8].
Triple-negative breast cancers (TNBC) are “aggressive” and highly malignant tumors characterized
by the lack of expression of estrogen-, progesterone-, and epidermal growth factor type 2 (HER2)
receptors, thereby being poorly responsive to hormonal therapies and to HER2-targeting drugs.
This makes the TNBC histotype usually associated with worse prognosis than other breast tumors [9].
The limitation of treatment options against TNBC has prompted multiple approaches attempting to
identify novel compounds that might counteract neoplastic cell growth. On the other hand, a thorough
biological characterization of such compounds and the elucidation of their molecular mechanism of
action is a necessary aspect for the development of targeted therapies.
The sea cucumber Holothuria tubulosa is a widespread species in the Mediterranean Sea and one
of the main species receiving rising commercial interest, being a seafood rich with nutrients and
suitable for human consumption [10]. Dealing with biomedical applications, methanol extracts of this
marine invertebrate were shown to restrain the inflammatory process in experimentally oedematous
mice [11]. More recent studies have highlighted that coelomocytes, the immune mediator cells
contained in the coelomic fluid (CF) of the animal, represent a source of antimicrobial substances
and diffusible haemolytic factors active on rabbit and sheep erythrocytes [12,13]. These findings
prompted an expansion of the investigation on the pharmacological potential of H. tubulosa-derived
components, whose massive procurement represents an easy task due to the extensive dissemination
of this aquatic organism.
In the present study, we examined the effect of the exposure of the TNBC cell line MDA-MB231
to total and filtered aqueous extracts of the CF obtained from H. tubulosa. The cell line chosen as the
model system for this investigation is derived from a pleural effusion of a TNBC of basal subtype
and displays several characteristics related to a highly malignant phenotype, such as the inactivation
of p53 due to a mutation in codon 280 of exon 8, and the ability to form metastases in vivo [14–16].
In particular, our goal was to examine in a comprehensive fashion the CF extract-mediated modulation,
if present, of viability and proliferative behaviour, cell cycle distribution, apoptosis and autophagy
events, and mitochondrial metabolic/cell redox state. The results obtained indicate that both total and
fractionated CF extracts are potent inhibitors of TNBC cell growth acting through both an impairment
of cell cycle progression and mitochondrial respiration and a stimulation of cellular autophagy.
2. Materials and Methods
2.1. Catching and Safekeeping of the Animals
A sample of 120 mature sea cucumbers (Holothuria tubulosa, Figure 1), approximately 11 ± 0.98 cm
in length with a body weight of 46 ± 7.5 g, was collected from the Gulf of Palermo (Sicily, Italy) at
a depth of 5–10 m, near a grassland of Posidonia oceanica, and the animals were manipulated after
2 weeks of acclimation in an aquarium filled with artificial sea water (0.425 M NaCl; 9 mM KCl;
9.3 mM CaCl2·2H2O; 0.0255 M MgSO4·7H2O; 0.023 MgCl2·6H2O; 2 mM NaHCO3 pH 8.0) at 15 ± 2 ◦C
with constant oxygenation. The animals were fed with commercial invertebrate food (Algamac 3000,
Aquafauna Bio-Marine Inc., Hawthorne, CA, USA).
2.2. Bleeding Procedure and Preparation of CF Extracts
The animals were cut making an incision measuring 3–5 cm on the anterior-dorsal side using a
scalpel, paying specific attention not to injure the internal organs. The CF was collected in several plastic
beakers covered by a filter, kept on ice, and then transferred to polycarbonate tubes and immediately
centrifuged at 1000 g for 10 min at 4 ◦C to remove the coelomocytes. Once separated from the cellular
component, an aliquot of CF was stored at −80 ◦C and the remaining volume was filtered using
Corning Spin-X UF 6 concentrators equipped with polyethersulfone membranes (10K MWCO; Corning
Inc., Tewksbury, MA, USA). The tubes were centrifuged at maximum speed (4000 g) for approximately
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3–4 h at 4 ◦C, and the filtered CF was stored at −80 ◦C. Then, both the total and filtered CFs, hereafter
referred to as total extract and 10K fraction, respectively, were lyophilized in an Alpha 2–4 LD plus
freeze-dryer (Martin Christ, Osterode am Harz, D). Aliquots of total extracts and 10K fractions were
resuspended in the minimum volume of sterile distilled water and the protein concentration was
measured with the Qubit Protein Assay Kit in the Qubit 3.0 fluorometer (ThermoFisher, Waltham, MA,
USA), according to the manufacturer’s instructions.
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2.3. Cell Cultures
MDA-MB231 TNBC cells were cultured in D-MEM medium purchased from Sigma, St. Louis,
MO, USA, supplemented with 10% foetal calf serum (FCS; ThermoFisher) and antibiotic/antimycotic
mixture (100 U/mL penicillin, 100 µg/mL streptomycin, and 2.5 mg/L amphotericin B; ThermoFisher)
at 37 ◦C in a 5% CO2 atmosphere.
2.4. MTT Assay
Cell viability was assessed by an MTT assay [17]. Briefly, MDA-MB231 cells in exponential
growth were plated at a concentration of 5500 cells/well in a 96-well plate, allowed to adhere overnight,
and then treated with different concentrations of total extracts and 10K fractions for either 24 or 48 h.
After addition of MTT and incubation with the solubilization buffer, the absorbance of the dissolved
formazan was measured in an automated microplate reader (λ = 550 nm). Cell viability ratio between
treated cells and controls was determined and the half maximal inhibitory concentrations (IC50)
evaluated with the online IC50 calculator available at https://www.aatbio.com/tools/ic50-calculator
(accessed June 2019).
2.5. Flow Cytometry
Flow cytometric assays were performed on treated and control cells as described in [18,19], using a
FACSCanto instrument (BD Biosciences, Franklin Lakes, NJ, USA). All the data were analyzed with
Flowing Software v.2.5.1. Gating in the FSC vs. SSC plot was performed before the specific analyses to
exclude debris, which displayed low FSC values.
For the analysis of cell cycle distribution, cells were fixed with cold 70% ethanol, incubated with
40 µg RNase A/mL, and stained with 20 µg propidium iodide/mL.
The externalization of phosphatidylserine, a hallmark of apoptotic events, was checked with the
Annexin V-FITC kit (Canvax Biotech, Cordoba, Spain) according to the manufacturer’s instructions.
The transmembrane mitochondrial potential (MMP) was checked using the mitochondria-selective
dye JC1 (Molecular Probes, Eugene, OR, USA), which undergoes a fluorescence emission shift from
green (~529 nm) to red (~590 nm) in case of physiologic MMP, whereas, in case of loss of MMP,
a decrease in the red/green fluorescence intensity ratio can be observed. A valinomycin-treated positive
control was included in the analysis.
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The production of reactive oxygen species (ROS) was evaluated using the ROS Detection Assay
Kit (Canvax Biotech) following the manufacturer’s instructions. A H2O2-treated positive control was
included in the analysis.
The modulation of the autophagic behavior was checked via the flow cytometric quantification of
i) the acidic vesicular organelles (AVOs), and ii) the autophagic markers beclin-1 and microtubule-
associated protein light chain-3 (LC3), both total and as LC3-II form. For i), after cell fixing with
cold 70% ethanol, cells were stained with 100 µg acridine orange/mL (Sigma) for 20 min in the dark.
For ii), two different procedures were followed in the case of either beclin-1 and total LC-3 or LC3-II
quantitation. For beclin-1 and total LC3 detection, cells were fixed with HistoChoice (Amresco, Solon,
OH, USA) for 30 min at ambient temperature, washed with 2% FCS-containing phosphate-buffered
saline (PBS), and incubated with the primary antibody dissolved in 0.1% Triton X-100 + 2% FCS +
40 µg propidium iodide/ml in PBS for 30 min. The antibodies used in the present study were rabbit
polyclonal anti-beclin-1 (H-300, sc-11427, Santa Cruz Biotechnology, Dallas, TX, USA; working dilution
1:50, as recommended by He et al. [20]) and rabbit polyclonal anti-LC3 (L8918, Sigma; working dilution
1:250). Negative controls were prepared with the omission of the primary antibody. After exhaustive
washing, the samples were incubated for 30 min with the secondary antibody (FITC-conjugated goat
anti-rabbit IgG whole molecule, F0382, Sigma; working dilution 1:80), washed three times in PBS,
and submitted to flow cytometry. For LC3-II detection, according to the procedure described by
Eng et al. [21], unfixed cells were rinsed with PBS + 0.05% saponin (Sigma) to allow the extraction of
the non-autophagosome-associated soluble LC3-I, and then incubated with the primary and secondary
antibodies as previously reported in this paragraph, with the exception that saponin was always
present in the antibody dilution buffers and replaced Triton X-100.
2.6. Statistics
Statistics were checked through ANOVA test with SigmaPlot 11.0 software (SYSTAT, San Jose, CA,
USA). A p-value < 0.05 was considered statistically significant.
3. Results
In a first set of experiments, we checked the effect of dose- and time-dependent incubation
with total extracts and 10 K fractions on MDA-MB231 cell survival and growth via MTT assay.
As shown in Figure 2, when cells were exposed for 24 h and 48 h to both samples, they underwent
a concentration-dependent decrease of cell viability and proliferation. At the highest concentration
tested, i.e., 15 µg/mL, the 10K fraction was more potent than the total extract in inhibiting cell viability
and growth after both 24 and 48 h of incubation. The average IC50 was found to be 12.6 and 11.15 µg/mL
at 24 h exposure and 10.1 and 10.45 µg/mL at 48 h exposure for the total extract and 10K fraction,
respectively. Once the cytotoxicity of the two preparations on MDA-MB231 cells was confirmed, all the
subsequent experiments were performed after cell exposures to total extracts and 10K fractions at the
corresponding IC50 for 24 and 48 h.
In order to get more insight into the biological basis of the cytotoxic activity exerted by the total
extracts and 10K fractions on triple-negative MDA-MB231 cells, we checked their effects on cell cycle
distribution, apoptosis induction via evaluation of phosphatidylserine externalization, mitochondrial
transmembrane potential (MMP) state, ROS production, and autophagy modulation, the latter via
quantitation of the acidic vesicular organelles (AVOs) and of specific intracellular biochemical markers,
i.e., beclin-1, total LC3 and LC3-II.
First, we tested which kind of perturbation was induced by treatments on MDA-MB231 cell cycle.
Figure 3 shows that, when compared to the control, 48 h exposure to both preparations induced an
accumulation of cells in S phase fraction, more conspicuous for 10K fraction (control vs. total extract
vs. 10K fraction = 5.43% vs. 17.7% vs. 23.5%), and a decrease of G2/M fraction (control vs. total extract
vs. 10K fraction = 59.48% vs. 46.6% vs. 47.2%). In addition, the 10K fraction determined a decrease
also of the G0/G1 fraction (control vs. 10K fraction = 33.91% vs. 26.53%), which was not observed after
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exposure to the total fraction. No modification of cell distribution in the cycle phases was recorded at
24 h exposure to both preparations with respect to control.
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Figure 3. Cell cycle distribution of MDA-MB-231 cells exposed to total extracts and 10K fractions for
24 (A) and 48 h (B), compared to control conditions. Error bars correspond to the standard error of the
mean (s.e.m.) of three independent measurements. * p < 0.05.
Samples of control and treated cells were then submitted to annexin V-FITC/propidium iodide
staining in order to test the effect of the total extract and the 10K fraction on phosphatidylserine
externalization, as a hallmark of induction of apoptosis, after 24 and 48 h of treatment. The data
obtained showed no difference between control and exposed cells with the almost total absence of
apoptotic annexin+/propidium iodide− cells at all times of investigation (Figure 4), demonstrating that
programmed cell death was not involved in cytotoxicity.
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The possible impairment of the mitochondrial function was evaluated by checking with the
JC1 probe the MMP status following cell exposure to the preparations. As shown in Figure 5, flow
cytometric analyses reveal a loss of the MMP in treated cells, the percentage of low red-emitting cells
(bottom quadrant) being about 89% and 81% after 24 h exposure and about 73% and 74% after 48 h
exposure to total extracts and 10K fractions, respectively, vs. approximately 40% and 45% in control
cells in the two time intervals.
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Figure 5. Representative flow cytometric analyses of the transmembrane mitochondrial potential
(MMP) in control (A,E), total extract- (C,G), and 10K fraction-treated (D,H) MDA-MB231 cells for
24 (A–D) and 48 h (E–H). Dot plots (B) and (F) show the parallel positive controls of valinomycin-treated
cells. The values indicated in the bottom quadrants in each frame quantitate the percentage of low
red-emitting cells that underwent dissipation of MMP. The results are expressed as mean ± s.e.m. of
triplicate assays.
Biology 2019, 8, 76 7 of 14
The imbalance of cell redox state was assayed via evaluation of ROS production. As shown
in Figure 6, after gating to exclude the population of low-fluorescence-emitting dead cells from
the analysis, the results obtained indicate that both 24 and 48 h exposure to total extracts and 10K
fractions did not result in the overaccumulation of total intracellular ROS (superoxide anion, hydrogen
peroxide, hydroxyl radical and singlet oxygen), being the fluorescence intensities comparable to those
of untreated controls and smaller than those of positive controls.
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Lastly, we checked whether the CF preparations could exert an effect on the modulation of the
autophagic activity by TNBC cells. A first set of assays was performed to evaluate the possible
modification in the amount of AVOs, a hallmark of autophagy, through staining with acridine orange,
a cell-permeable fluorescent dye that can be captured within the acidic compartments after uptake
and protonation. Interestingly, although as already reported, the autophagy rate of the cell line and
consequently the amount of red-emitting MDA-MB231 cells are constitutively high [18,19,22]. Figure 7
shows that a further increase of fluorescent events can be observed after exposures to the preparations
for 24 and 48 h, being more conspicuous in the presence of the 10K fraction upon 24 h of treatment.
It is widely recognized that acridine orange is a reliable marker for monitoring autophagy only
when used in conjunction with other molecular markers [23]. For this reason, to confirm the acridine
orange data, we then checked the intracellular accumulation levels of beclin-1, whose increase is a
hallmark of the onset of autophagy, and LC3-II, the autophagosome-linked lipidated form of LC3-I
protein, whose amount is closely correlated with that of the organelles, thereby being a good indicator
of their formation. For LC3-II quantification, unfixed cells were resuspended in saponin-containing
buffers before the flow cytometric immunoassays in order to extract and discard the amount of
immunoreactive soluble cytosolic LC3-I [21]. In addition, since conflicting evidence exists regarding
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the upregulation of LC3 transcription levels in autophagy-leading conditions of cellular stress [24–26],
we also examined the effect of MDA-MB231 cell exposure to total extracts and 10K fractions on the
intracellular accumulation of total LC3 via flow cytometric immunoassays performed on fixed cells.
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Figure 7. Representative flow cytometric analyses of control (A,D), total extract- (B,E), and 10K
fraction-treated (C,F) MDA-MB231 cells stained with acridine orange for evaluation of acidic vesicular
organelle (AVO) accumulation after 24 (A–C) and 48 h (D,F) of exposure. The percentage indicated
in the top quadrants refers to the high red fluorescence-emitting events. The results are expressed as
mean ± s.e.m. of triplicate assays.
The histograms in Figure 8 confirm that MDA-MB231 cells have a high basal autophagy level and
that an accumulation of autophagy markers may be observed after exposure to the CF preparations.
In fact, control cells display a 1.4- to 2-fold higher LC3-II-related fluorescence intensity than the
negative controls, thus indicating a constitutive activation of autophagosome formation in unexposed
conditions. On the other hand, the amount of beclin-1 is further upregulated by about 1.9-fold in
the presence of both total extract and 10K fraction after 24 h of treatment, being instead comparable
to that of the control at 48 h of exposure. Also, the LC3-II amount further increases after 24 h of
treatment, more prominently in the presence of the 10K fraction (10K fraction: About 3.1-fold; total
fraction: 1.3-fold vs. control), whereas after 48 h, although remaining upregulated, it displays a more
moderate increase of fluorescence in 10K fraction-exposed cells (10K fraction: About 1.4-fold; total
fraction: 1.2-fold vs. control). Moreover, flow cytometric immunoassays for total LC3 show a greater
intracellular accumulation of the whole amount of the protein at 24 h of exposure to both preparations,
being more conspicuous in the presence of the 10K fraction (10K fraction: About 3.6-fold; total fraction:
2.35-fold vs. control), likely due to an early transcriptional activation. After 48 h of exposure to the CF
preparations, total LC3 amount is comparable to that of control cells. Cumulatively, our results suggest
the occurrence of an early autophagy induction upon cell exposure to CF extracts, followed by a flux
decline approximately down to the levels of control samples between 24 and 48 h of treatment.
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Figure 8. Histograms showing the intensity of the immunofluorescence of beclin-1 (A), LC3-II (B),
and total LC3 (C) in control and treated MDA-MB-231 cells after 24 and 48 h of exposure. Negative
controls lack the incubation with the primary antibody. Error bars correspond to the standard error of
the mean (s.e.m.) of three independent measurements. * p < 0.05.
4. Discussion
Breast cancer, the most common diagnosed tumour among females, is a widespread neoplastic
histotype accounting for ab ut 12% of all cancers, whose rat s re increasing worldwide [27].
Approximately 15% of breast cancers are of th TNBC subtype, which l cks effective targeted
therapies, thereby being regarded as the most aggressive form of breast carcinomas to date [28].
In the attempt to identify novel substances endowed with anti-breast cancer action, here we have
tested the cytotoxic effect of aqueous extracts of CFs from H. tubulosa on MDA-MB231 TNBC cells,
Biology 2019, 8, 76 10 of 14
also comparing the activity of the crude extracts to that of the filtered counterparts retaining peptides
and other water-soluble components with MW < 10 kDa. Our overall results indicate that although
the two preparations play the same biological role, the 10K fraction displays a lower IC50 at 24 h and
appears more powerful in acting upon the mitochondrial function and the autophagy rate at 24 h,
thus suggesting that the component(s) responsible for such early effects may be more concentrated in
the filtered samples.
To our knowledge, here we report the first data linking cell exposure to H. tubulosa-derived extracts
to the modulation of the autophagic event. In particular, our results on the initial biological effects that
occur 24 h after cell exposure to the CF extracts highlight autophagy upregulation and MMP dissipation,
but with undetectable ROS overproduction, which remains unchanged thereafter. Autophagy, which is
a cellular homeostatic function, implicates the autodigestion of cytoplasmic substrates for their removal
or turnover after sequestration in the autophagic vacuoles, multi-membrane-bound structures, that then
fuse with lysosomes generating AVOs or autolysosomes [29]. The role of autophagy in breast cancer
is complex and controversial, since it may operate as a tumor-suppressor mechanism addressing
neoplastic cells to death, but, on the other hand, it can act to protect cancer cells in conditions
of oxygen and nutrient shortage and allow their rapid proliferative rate by providing energy and
basic elements [30]. MDA-MB231 cells are endowed with a constitutively elevated autophagy rate.
Inhibition of autophagy was proven to render them susceptible to the lethal effect of chemicals in
various experimental conditions (e.g., [18,19,31,32]); on the other hand, lethal effects on this cell line
induced by several autophagy inducers have been reported in the literature (e.g., [33,34]).
In this paper, the ability of the preparations under study to modulate the autophagic rate
was checked via two different endpoints, i.e., the flow cytometric evaluations of the intracellular
accumulations of AVOs and of the protein markers LC3 (total and LC3-II form) and beclin-1,
the latter being a key component of the autophagic machinery belonging to the signal-initiating
class III phosphatidylinositol-3 kinase complex [35]. Interestingly, the collective data presented here
demonstrate that the CF extracts determine autophagy upregulation as indicated by the increase
in AVOs, beclin-1, LC3-II, and total LC3, similarly to what was observed for MDA-MB231 in other
experimental conditions (e.g., [36,37]). The decrease of the levels of beclin-1 and LC3-II approximately
down to those of controls at 48 h of exposure may reflect their intra-autophagosomal degradation
by lysosomal hydrolases after the formation of autophagosomes, whereas that of total LC3 may be
due to a decrement in protein synthesis [25,38]. However, it is worth mentioning that acridine orange
may also detect lysosomes and is thus not specific to autolysosomes, and assessment of beclin-1 and
LC3-II levels is one of the most commonly used markers for autophagy, but as suggested by Klionsky
et al. [23], should be coupled to other markers to give exhaustive indication of autophagic activity.
Therefore, further studies are required to accurately determine whether autophagy is affected and
autophagic activity is modified in CF extracts-treated MDA-MB231 cells.
It is known that treatment of MDA-MB231 cells with compounds that induce mitochondrial
dysfunction and loss of MMP selectively results in the activation of autophagy, and that the originated
autophagosomes are mainly addressed to engulf the damaged organelles via binding through an
endogenous protein complex that contains the proteins LC3-II and Mitofusin 2 [39]. Therefore, our results
suggest that the upregulation of autophagy observed after cell exposure to the CF preparations might
be, at least in good part, of the “mitophagic” type. This hypothesis is substantiated by the absence of
activation of cell death program, as observed after cell exposure to CF preparations. In fact, it is also
known that autophagosomal degradation of the damaged mitochondria reduces the intracytoplasmic
release of cytochrome C and inhibits the onset of intrinsic apoptosis [32]. It must also be taken into
consideration, however, that MDA-MB-231 cells are provided with a mutant p53 and high levels of
phospholipase D, both sustaining survival, thereby being intrinsically resistant to apoptosis [40,41].
Moreover, the autophagic clearance of the damaged mitochondria can also determine an interference
with ROS production that might account for the inability to detect their increased accumulation in
our experimental conditions, as found in other cases of MMP collapse in MDA-MB231 cells [18,19,31].
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Interestingly, Gonzalez et al. [42] have reported the occurrence of a cytoprotective antioxidant response
in MDA-MB231 cells induced by ROS-triggered autophagy upregulation, which implies the onset of a
feedback loop between the free radical-protecting Keap1-Nrf2 pathway and the autophagy-related
protein Atg7.
Treatment with both CF preparations was shown to exert a selective effect on cell cycle distribution
in a later timeframe, i.e., between 24 and 48 h of exposure, by producing a significant accumulation
of MDA-MB231 cells at the S phase. It is conceivable that cells, increasingly damaged during the
early times of exposure to the CF extracts, in this time lapse start to meet failures in DNA replication
activity with a consequent slowing down of the specific cycle phase, if not an arrest, compared to
controls [43]. It is worth mentioning that substances that promote autophagy are also known to alter
the progression of the cell cycle preferentially in the S phase (e.g., [44,45]). Interestingly, the restraining
property of the CF extracts from H. tubulosa reported here is shared with the aqueous extracts from
another Mediterranean Sea cucumber, i.e., Holothuria polii, which were found to arrest MDA-MB231
cells in the S phase after three days of exposure [46].
Further elucidation of these and other autophagy-related molecular circuits through which the
extracts of H. tubulosa CF accomplish their TNBC cell death activity will be carried out in future studies.
Nonetheless, our work presents interesting aspects in that it expands the list of the preparations of
natural origin that upregulate autophagy, while inhibiting tumor cell viability and provides more
insight into the role played by autophagy in breast cancer cell death. It is indeed known that other
echinoderms, including the Holothurian species, produce small molecules or amino acids that are able
to induce autophagy in cancer cells [47–49].
A limitation of this study is the lack of identification of the CF component(s) responsible for the
observed effects, which has/have not been isolated to date. On the other hand, the data reported here
strongly suggest that such water-soluble constituent(s) is/are resistant to lyophilization, resuspension,
and freeze-thawing cycles, and must supposedly have a MW < 10 kDa since the biological activity
is retained and ameliorated after filtration of the crude extract. In light of the literature data, sea
cucumber-derived anti-cancer molecules that exhibit this size fall into the categories of triterpenes,
glycosaminoglycans, and peptides [8,50]. At present, we cannot exclude the existence of potential
synergic activities, as reported by Guo et al. [51].
A great deal of literature data have widely discussed the molecular nature of potential anti-cancer
compounds obtained from sea cucumbers [52]. Notably, the majority of them consist of molecules
recovered after fractionation of extracts in organic solvents, and hence our work adds one more
reference to the limited number of publications that instead focus on the cytotoxic activity of aqueous
extracts and their components (e.g., [46,53,54]).
5. Conclusions
In summary, we have shown that extracts from H. tubulosa CF are cytotoxic towards TNBC
cells in vitro and therefore merit further investigation aimed at the characterization of the “active
ingredient(s)” present in the samples under study to develop novel promising prevention and/or
treatment agents efficacious against highly metastatic breast carcinomas.
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